ADC Therapeutics SA

ADCT
Exchange
NYSE
Industry
Pharmaceutical Preparations
SEC CIK
0001771910

Price chart

Open-market purchases and sales by ADCT insiders, newest first.

Insider trades
Filed (ET)Trade dateInsiderTransactionSharesAvg priceValueShares afterHolding changeFiling
Apr 2, 20269:00 PM ETMar 31 – Apr 2, 2026Redmile Group, LLC and 2 others10% OwnerSSaleCommon Stock−3M$3.3393−$10.02M12.67M−19.1%SEC
Apr 2, 20269:00 PM ETMar 31 – Apr 2, 2026Redmile Group, LLC and 2 others10% OwnerSSaleCommon Stock−2.88M$3.3393−$9.62M10.27M−21.9%SEC
Oct 28, 20259:00 PM ETOct 27, 2025Redmile Group, LLC and 2 others10% OwnerPPurchaseCommon Share · Derivative+3.85M$3.90+$15M3.85M–SEC
Oct 28, 20259:00 PM ETOct 27, 2025Redmile Group, LLC and 2 others10% OwnerPPurchaseCommon Share · Derivative+3.85M$3.90+$15M3.85M–SEC
Jun 13, 20256:00 PM ETJun 11, 2025Redmile Group, LLC and 2 others10% OwnerPPurchaseCommon Share · Derivative+15.73M$3.432+$54M15.73M–SEC

The largest institutional positions in ADCT at the end of Q2 2026.

Institutions holding ADCT in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Nantahala Capital Management, LLC24,652,368$26.38M0.80%+19,054,935+340.4%Added
Redmile Group, LLC11,526,710$12.33M0.83%−3,943,792−25.5%Reduced
TCG Crossover Management, LLC11,390,175$12.19M0.29%00.0%Unchanged
Prosight Management, LP7,824,749$8.37M1.44%−475,251−5.7%Reduced
BlackRock, Inc.7,020,093$7.51M0.00%+769,346+12.3%Added